Title |
Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance
|
---|---|
Published in |
Arthritis Research & Therapy, December 2017
|
DOI | 10.1186/s13075-017-1493-8 |
Pubmed ID | |
Authors |
Nilasha Ghosh, Eric M. Ruderman |
Abstract |
Current classification criteria for axial spondyloarthritis (axSpA) provide for the inclusion of patients with a wide range of presentations and manifestations. While not considered a formal subclassification, patients are often divided into radiographic or nonradiographic axSpA based on the presence or absence of radiographic sacroiliitis. This review will focus on nonradiographic axSpA and will discuss clinical manifestations of disease that distinguish, or in many cases do not distinguish, this entity from other individuals with axSpA. This review will also cover treatment paradigms for nonradiographic axSpA, particularly the use of biologic therapies, where current data suggest that nonradiographic disease should be managed largely the same as radiographic disease, or classical ankylosing spondylitis. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 31% |
United Kingdom | 2 | 15% |
Spain | 2 | 15% |
Maldives | 1 | 8% |
Ecuador | 1 | 8% |
Singapore | 1 | 8% |
Mexico | 1 | 8% |
Unknown | 1 | 8% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 9 | 69% |
Practitioners (doctors, other healthcare professionals) | 2 | 15% |
Scientists | 1 | 8% |
Science communicators (journalists, bloggers, editors) | 1 | 8% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 55 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 15% |
Student > Master | 6 | 11% |
Student > Bachelor | 6 | 11% |
Student > Ph. D. Student | 5 | 9% |
Student > Postgraduate | 5 | 9% |
Other | 11 | 20% |
Unknown | 14 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 29 | 53% |
Immunology and Microbiology | 4 | 7% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Agricultural and Biological Sciences | 1 | 2% |
Other | 5 | 9% |
Unknown | 13 | 24% |